1. Holroyd CR, Seth R, Bukhari M, Malaviya A, Holmes C, Curtis E, Chan C, Yusuf MA, Litwic A, Smolen S, Topliffe J, Bennett S, Humphreys J, Green M, Ledingham J. The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis. Rheumatol. Sept 18, 2018. 
  2. Nikiphorou E, Negoescu A, Fitzpatrick JD, Goudie CT, Badcock A, Ostor AJ, Malaviya AP. Indispensible or intolerable? Methotrexate in rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort. J Rheumatol. 2014; 33 (5): 609-14
  3. Malaviya AP, Ledingham J, et al. The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis. Rheumatology. 2014; 56(7):1344-6
  4. Malaviya AP, Ostor AJK. Drug adherence and compliance with biologic DMARDS with a special emphasis on the benefits of subcutaneous abatacept. Patient Pref Adherence. 2012.
  5. Malaviya AP, Ostor A. ‘The Harlequin Sign’. Benign blush or the bearer of bad news. Arthritis Rheum. 2012 Apr 5. doi: 10.1002/art.34487.
  6. Malaviya AP, Ostor AJ. Rheumatoid arthritis and the era of biologic therapy. Inflammopharmacology. 2012;20(2):59-69
  7. Malaviya AP, Hall FC. Targeting CVD in chronic connective tissue disease. Practitioner. 2012. 256(1747): 21-26
  8. Malaviya AP, Ostor AJ. Early diagnosis crucial in ankylosing spondylitis. Practitioner. 2011;255(1746): 21-24
  9. Malaviya AP, Dasgupta B. An approach to the diagnosis and assessment of childhood vasculitis. Indian J Paed (Rheumatology suppl). 2009.
  10. Burr ML, Malaviya AP, et al. Rituximab in Rheumatoid Arthritis following anti-TNF associated Tuberculosis. Rheumatol. 2008; 47: 738-739
  11. Patel AL, Malaviya AP, et al. Kerosene Poisoning- Varied Systemic Manifestations. JAPI. 52(1):65-66
  12. Patel AL, Malaviya AP, et al. Primary systemic amyloidosis. JAPI. 2004;52:335-7
  13. Patel AL, Malaviya AP, et al. Patent ductus arteriosus with a left to right shunt in a 64-year-old asymptomatic male. JAPI. 2004;52:753-5.